Phuturdex › Diseases › Radiation Injuries
Drugs in development · updated 30 October 2026
Radiation Injuries: drugs in development
As of 30 October 2026 there are 9 active clinical trials (recruiting or ongoing, phases I–III) on 13 drugs for radiation Injuries. 3 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| Chemoradiotherapy | II–III | 1 | NCT06758830 |
| ChlorophyllinSodium Copper Chlorophyllin | III | 1 | NCT07837713 |
| Hetrombopagherombopag | II | 1 | NCT06745219 |
Sorted by most advanced phase and number of active trials.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| Bevacizumabavastin, MVASI | III | 1 | NCT06888817 |
| CarboplatinCarboplatine, Paraplatin | III | 1 | NCT07008716 |
| CisplatinCis Platinum, Cisplatine | III | 1 | NCT07008716 |
| CopperMiudella®, Paragard T 380A® | III | 1 | NCT07837713 |
| DexamethasoneDexametasone, Dextenza | III | 1 | NCT06888817 |
| EtoposideAvopef®, Etopophos Preservative Free® | III | 1 | NCT07008716 |
| Triamcinolone Acetonidezilretta, Kenalog { | III | 1 | NCT07189572 |
| GoserelinZOLADEX | I–II | 1 | NCT05003752 |
| Lithium | II | 1 | NCT06051240 |
| LisinoprilQbrelis®, Zestril® | Early I | 1 | NCT05530655 |
Sorted by most advanced phase and number of active trials.
All 13 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Cardiotoxicity 21 drugs
- Radiation Pneumonitis 5 drugs
- Breast neoplasm 593 drugs
- Ototoxicity 3 drugs
- Diffuse large B-cell lymphoma 177 drugs
- Lymphoma 252 drugs
- Lung neoplasm 348 drugs
- Interstitial lung disease 65 drugs
- Hodgkin lymphoma 93 drugs
- Heart failure 104 drugs
- Cardiomyopathies 23 drugs
- Sensorineural hearing loss 8 drugs
Broader categories
- Wounds and Injuries 25 drugs
- Neoplasm 671 drugs
- Urogenital Diseases 16 drugs
- Urogenital neoplasm 38 drugs
- Genital Diseases 7 drugs
- Male urogenital disease 19 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: NLM MeSH; NLM MeSH term: D011832 “Radiation Injuries”.